Skip to main content

Cancer Symptoms and Side Effects of Treatment

  • Chapter
  • First Online:
The MASCC Textbook of Cancer Supportive Care and Survivorship
  • 1331 Accesses

Abstract

Cancer can present without symptoms when it is discovered incidentally or as a result of screening. A feature of a symptom of cancer is persistence. Symptoms can be systemic, such as weight loss or fatigue, or organ specific, such as pain or cough. When treatment commences the symptoms of cancer must be distinguished from the side effects of therapy. These can be characterised by their temporal relation to the treatment as immediate, delayed by days, weeks of months or late effects which occur years later. These symptoms and side effects in turn must be distinguished from the symptoms of concomitant illnesses or side effects of other medication. A multidisciplinary approach is commonly used to manage cancer and parallel care between palliative care clinicians and oncologist is an ideal model for symptom control. Maximising quality of life is the overall aim of treating patients with cancer and this includes recognising all of the parameters, such as spiritual well-being, which impact on overall quality of life, and takes into account the balance between the efficacy and toxicity of treatments. Finally, survivorship embraces late physical effects of the cancer and its treatment as well as psychosocial issues and the adjustment to life after a diagnosis of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ramos M, Arranz M, Taltavull M, March S, Cabeza E, Esteva M. Factors triggering medical consultation for symptoms of colorectal cancer and perceptions surrounding diagnosis. Eur J Cancer Care (Engl). 2010;19:192–199.

    Article  CAS  Google Scholar 

  2. Dexter AJ, Cheong J. Neurosurgical involvement with cancer patients. In Robotin M, Olver I, Girgis A, eds. When Cancer Crosses Disciplines. London: Imperial College Press 2009:343–365.

    Chapter  Google Scholar 

  3. Pipkin CA, Lio PA. Cutaneous manifestations of internal malignancies: An overview. Dermatol Clin. 2008;26:1–15.

    PubMed  CAS  Google Scholar 

  4. Fattal C, Gault D, Leblond C et al. Metastatic paraplegia: care ­management characteristics within a rehabilitation centre. Spinal Cord. 2009;47:115–121.

    Article  PubMed  CAS  Google Scholar 

  5. Park YH, Lee S, Cho EY et al. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status. Cancer Chemother Pharmacol. 2010;66:507–516.

    Article  PubMed  CAS  Google Scholar 

  6. Beckles MA, Spiro SG, Colice GL, Rudd RM. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests and paraneoplastic syndromes. Chest. 2003;123:97S–104S.

    Article  PubMed  Google Scholar 

  7. Giess CS, Schwartz LH, Bach AM, Gollub MJ, Panicek DM. Patterns of neoplastic spread in colorectal cancer: implications for surveillance CT studies. Am J Roentgenol. 1998;170:987–991.

    CAS  Google Scholar 

  8. Long MA, Husband JE. Features of unusual metastases form ­prostate cancer. Br J Radiol. 1999;72:933–941.

    PubMed  CAS  Google Scholar 

  9. Goolsby TV, Lombardo FA. Extravasation of chemotherapeutic agents: prevention and treatment. Semin Oncol. 2006;33:139–143.

    Article  PubMed  CAS  Google Scholar 

  10. Lee C, Gianos M, Klaustermeyer WB. Diagnosis and management of hypersensitivity reactions related to common cancer chemo­therapy agents. Ann Allergy Asthma Immunol. 2009;102:187–179.

    Google Scholar 

  11. Olver IN. Prevention of chemotherapy-induced nausea and ­vomiting: Focus on fosaprepitant. Ther Clin Risk Manag. 2008;4(2):1–6.

    Google Scholar 

  12. Heuser M, Ganser A, Bokemeyer C. Neutropenia: Review of ­current guidelines. Semin Oncol. 2007;44:148–156.

    CAS  Google Scholar 

  13. Keefe DM, Schubert MM, Elting LS, Sonis ST et al; Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109:820–831.

    CAS  Google Scholar 

  14. Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced ­alopecia and effects on quality of life among women with breast cancer: a literature review. Psychooncology. 2008;17:317–328.

    Article  PubMed  Google Scholar 

  15. Vahid B, Marik PE. Pulmonary complications of novel antineoplastic agents for solid tumours. Chest. 2008;133:528–538.

    Article  PubMed  CAS  Google Scholar 

  16. Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Periph Nerv Syst. 2008;13:27–46.

    Article  CAS  Google Scholar 

  17. Darmon M, Ciroldi M, Thiery G, Schlemmer B, Azoulay E. Clinical review: Specific aspects of acute renal failure in cancer patients. Crit Care. 2006;10:211 (doi:1186/cc4907).

    Article  PubMed  Google Scholar 

  18. King PD, Perry MC. Hepatotoxicity of chemotherapy. Oncologist. 2001;6:162–167.

    Article  PubMed  CAS  Google Scholar 

  19. Bird BR, Swain SM. Cardiac toxicity in breast cancer survivors: Review of potential cardiac problems. Clin Cancer Res. 2008;14:14–24.

    Article  PubMed  CAS  Google Scholar 

  20. Hildebrand J. Neurologic complications of cancer chemotherapy. Curr Opin Oncol. 2006;18:321–324.

    Article  PubMed  CAS  Google Scholar 

  21. Meirow D, Schiff E. Appraisal of chemotherapy effects on reproductive outcome according to animal studies and clinical data. J Natl Cancer Inst Monogr. 2005;34:21–25.

    Article  PubMed  CAS  Google Scholar 

  22. Travis B, Rabkin CS, Brown LM et al. Cancer survivorship-genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst. 2006;98:15–25.

    Article  PubMed  Google Scholar 

  23. Fiorino C, Rancati T, Valdaqni R. Predictive models of toxicity in external radiotherapy: dosimetric issues. Cancer. 2009;115:3135–3140.

    Article  PubMed  Google Scholar 

  24. Kempster PA, Rollison RD. The Lhermitte phenomenon: variant forms and their significance. J Clin Neurosci. 2008;15:379–381.

    Article  PubMed  CAS  Google Scholar 

  25. Enami B, Lyman J, Brown A et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122.

    Article  Google Scholar 

  26. Friedlander PA, Bansal R, Schwartz L, Wagman R, Posner P, Kemeny N. Gemcitabine-related radiation recall preferentially involves internal tissue and organs. Cancer. 2004;100:1793–1799.

    Article  PubMed  Google Scholar 

  27. Kaasa S, Brenne E, Lund JA et al. Prospective randomised multicentre trial on a single fraction radiotherapy (8Gy x 1) versus multiple fractions (3Gy x 10) in the treatment of painful bone metastases. Radiother Oncol. 2006;79:278–284.

    Article  PubMed  Google Scholar 

  28. Brusamolino E, Baio A, Orlandi E et al. Long-term events in adult patients with clinical stage 1A-11A nonbulky Hodgkin’s ­lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single institution experience. Clin Cancer Res. 2006;12:6487–6493.

    Article  PubMed  CAS  Google Scholar 

  29. Brufsky A. Trastuzumab-based therapy for patients with ­HER2-positive breast cancer: form early scientific development to foundation care. Am J Clin Oncol. 2010;33:186–195.

    PubMed  CAS  Google Scholar 

  30. Bailey LJ, Sanson-Fisher R, Aranda S, D’Este C, Sharkey K, Schofield P. Quality of life research: types of publication output over time for cancer patients, a systematic review. Eur J Cancer. 2009;Oct 14 [Epub ahead of print].

    Google Scholar 

  31. Cimprich B, Janz NK, Northouse L, Wren PA, Given B, Given CW. Taking CHAGE: A self-management program for women following breast cancer treatment. Psychooncology. 2005;14:704–717.

    Article  PubMed  Google Scholar 

  32. Whitford HS, Olver IN, Peterson MJ. Spirituality as a core domain in the assessment of quality of life in oncology. Psychooncology. 2008;17:1121–1128.

    Article  PubMed  Google Scholar 

  33. Little M, Sayers EJ, Paul K, Jordens CFC. On surviving cancer. J R Soc Med. 2000;93:501–503.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ian N. Olver .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Society for Imaging Informatics in Medicine

About this chapter

Cite this chapter

Olver, I.N. (2010). Cancer Symptoms and Side Effects of Treatment. In: Olver, I. (eds) The MASCC Textbook of Cancer Supportive Care and Survivorship. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-1225-1_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1225-1_1

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4419-1224-4

  • Online ISBN: 978-1-4419-1225-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics